Divi's Laboratories Limited
NSE:DIVISLAB.NS
Sector
Location
Market Cap
USD 21.12 B
Share Price
USD 76.45
Avg Daily Volume
534,876
Change (1 day)
-0.12%
Change (1 year)
40.87%
Change (YTD)
7.30%
Divi's Laboratories Limited Selling, General, and Administrative Expenses (SG&A) for the year ending March 31, 2024: USD 25.78 M
Divi's Laboratories Limited Selling, General, and Administrative Expenses (SG&A) is USD 25.78 M for the year ending March 31, 2024, a -11.73% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
-
Divi's Laboratories Limited Selling, General, and Administrative Expenses (SG&A) for the year ending March 31, 2023 was USD 29.20 M, a -5.89% change year over year.
-
Divi's Laboratories Limited Selling, General, and Administrative Expenses (SG&A) for the year ending March 31, 2022 was USD 31.03 M, a 9.67% change year over year.
-
Divi's Laboratories Limited Selling, General, and Administrative Expenses (SG&A) for the year ending March 31, 2021 was USD 28.29 M, a 33.22% change year over year.
-
Divi's Laboratories Limited Selling, General, and Administrative Expenses (SG&A) for the year ending March 31, 2020 was USD 21.24 M, a 16.04% change year over year.
StockViz
Competitors
Zhangzhou Pientzehuang Pharmaceutical., Ltd
USD 28.43
600436.SS
-0.33
-1.15%
BioMarin Pharmaceutical Inc.
USD 59.01
BMRN
-0.75
-1.26%
Kyowa Kirin Co., Ltd.
USD 17.38
4151.T
-0.12
-0.67%
Abbott India Limited
USD 390.29
ABBOTINDIA.NS
-9.59
-2.40%
Sichuan Kelun Pharmaceutical Co., Ltd.
USD 4.91
002422.SZ
+0.03
0.69%
Chengdu Kanghong Pharmaceutical Group Co., Ltd
USD 5.62
002773.SZ
-0.09
-1.63%
Livzon Pharmaceutical Group Inc.
USD 4.98
1513.HK
-0.04
-0.76%
SCHOTT Pharma AG & Co. KGaA
USD 30.53
1SXP.F
+0.63
2.10%
Dong-E-E-Jiao Co.,Ltd.
USD 7.11
000423.SZ
-0.10
-1.37%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd
USD 7.39
688336.SS
-0.79
-9.71%
Kangmei Pharmaceutical Co., Ltd.
USD 0.30
600518.SS
-0.00
-1.12%
China Medical System Holdings Limited
USD 1.70
0867.HK
+0.01
0.60%
Gland Pharma Limited
USD 23.32
GLAND.NS
-0.02
-0.08%
Beijing Aosaikang Pharmaceutical Co., Ltd.
USD 3.65
002755.SZ
-0.11
-3.01%
Jilin Aodong Pharmaceutical Group Co., Ltd.
USD 2.66
000623.SZ
-0.03
-1.28%
Key Data
| Date | Selling, General, and Administrative Expenses (SG&A) | Research and Development (R&D) Expenses | Revenue | Revenue |
|---|
Competitors
Zhangzhou Pientzehuang Pharmaceutical., Ltd
USD 28.43
600436.SS
-0.33
-1.15%
BioMarin Pharmaceutical Inc.
USD 59.01
BMRN
-0.75
-1.26%
Kyowa Kirin Co., Ltd.
USD 17.38
4151.T
-0.12
-0.67%
Abbott India Limited
USD 390.29
ABBOTINDIA.NS
-9.59
-2.40%
Sichuan Kelun Pharmaceutical Co., Ltd.
USD 4.91
002422.SZ
+0.03
0.69%
Chengdu Kanghong Pharmaceutical Group Co., Ltd
USD 5.62
002773.SZ
-0.09
-1.63%
Livzon Pharmaceutical Group Inc.
USD 4.98
1513.HK
-0.04
-0.76%
SCHOTT Pharma AG & Co. KGaA
USD 30.53
1SXP.F
+0.63
2.10%
Dong-E-E-Jiao Co.,Ltd.
USD 7.11
000423.SZ
-0.10
-1.37%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd
USD 7.39
688336.SS
-0.79
-9.71%
Kangmei Pharmaceutical Co., Ltd.
USD 0.30
600518.SS
-0.00
-1.12%
China Medical System Holdings Limited
USD 1.70
0867.HK
+0.01
0.60%
Gland Pharma Limited
USD 23.32
GLAND.NS
-0.02
-0.08%
Beijing Aosaikang Pharmaceutical Co., Ltd.
USD 3.65
002755.SZ
-0.11
-3.01%
Jilin Aodong Pharmaceutical Group Co., Ltd.
USD 2.66
000623.SZ
-0.03
-1.28%